产品展示
![SW620 [SW-620]（人结肠腺癌细胞）](http://img3.yituig.com/products/big/20130507/201305070214566308.png)
优质供应
详细内容
SW620 [SW-620]（人结肠腺癌细胞）
上海义森生物科技有限公司
ATCC® Number: CCL-227™ Designations: SW620 [SW-620] Depositors: A Leibovitz Biosafety Level: 1 Shipped: frozen
SW620 [SW-620]（人结肠腺癌细胞）
上海义森生物科技有限公司
ATCC® Number: CCL-227™ Designations: SW620 [SW-620] Depositors: A Leibovitz Biosafety Level: 1 Shipped: frozen
SW620 [SW-620]（人结肠腺癌细胞）
上海义森生物科技有限公司
| ATCC® Number: | CCL-227™ |
| Designations: | SW620 [SW-620] |
| Depositors: | A Leibovitz |
| Biosafety Level: | 1 |
| Shipped: | frozen |
SW620 [SW-620]（人结肠腺癌细胞）
上海义森生物科技有限公司
| Medium & Serum: | See Propagation |
| Growth Properties: | adherent |
| Organism: | Homo sapiens （human） |
| Morphology: | epithelial |
| Source: | Organ: colon Tumor Stage: Dukes＇ type C Disease: colorectal adenocarcinoma Derived from metastatic site: lymph node |
| Cellular Products: | carcinoembryonic antigen （CEA） 0.15 ng/10 exp6 cells/10 days; transforming growth factor alpha; keratin; matrilysin |
| Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. |
上海义森生物科技有限公司
